Becton, Dickinson and Company · NYSE:BDX

Becton, Dickinson and — MDS20 (BD Medication Delivery Solutions 2020)

16 slides from Becton, Dickinson and's conference presentation, April 2020

  1. Slide 1: Presentation disclaimer

    These presentations were developed by the respective presenter(s), and the findings, interpretations, and conclusions contained or expressed with them do not necessarily reflect the views of BD. To the extent these presentations relate to specific products, such products should always be used in acc

  2. Slide 2: What can we do in education to reduce complications

    WAT) IN EDUCATION TO 2EDUCE COMPLICATIONS Gema Munoz-Mozas

  3. Slide 3: Necessary and prevalent VAD use with high failure

     Necessary and prevalent – most hospitalised patients require some VAD for therapy delivery  Associated risks (multiple insertion attempts, infiltration/ extravasation, occlusion, local or blood stream infection etc…)  High premature catheter failure (20-50% VADs fail before the end of therapy)

  4. Slide 4: VAD failure affects patients, practitioners and organisations

     VAD failure affects:  Patients (poor experience, delays in treatment…)  Health Care Practitioner (time wasting, frustration…)  Health Care Organisations (wasted resources, poor clinical outcomes…)  Best Evidence-based Practice and Guidelines (EPIC3; INS 2016; RCN 2016 and national and local gu

  5. Slide 5: Assessment and VAD selection

     Assessment and VAD selection  Aseptic Insertion  Daily Care and Documentation  Administration  Prompt Review and Removal

  6. Slide 6: Vascular access is multidimensional and complex

     Vascular Access is multidimensional and complex  Patients with different needs and other co- morbidities  Fragmentation of care  Lack of knowledge/ different levels of experience/ lack of consistency/ staff complacency  ‘Evidence-Practice’ gap

  7. Slide 7: Can we fix this?

  8. Slide 8: Centralised approach and co-ordination of VAD care

     Centralised approach and co-ordination of VAD Insertion Care and Maintenance based on the best evidence available  Follow up and trouble shoot VAD issues at the point of care  Improve patient experience  Raise awareness on VAD care and maintenance  Lead on clinical education and training

  9. Slide 9: Standardisation of IV practices

     Standardisation of IV Practices  Collaboration with IV Training and Competency assessment  VAD care and maintenance as part of Harm Free Care  Development of Mnemonic memory tools as a system of care for clinical staff

  10. Slide 10: F.R.E.D.D

     F.R.E.D.D  Functional: Flushing and aspirating, working well  Required: ‘In use?’ If not needed…REMOVE  Exit Side: VIP score  Dressing: Dated, replace if damped, loosened or soiled  Documentation: Inspected daily and documented

  11. Slide 11: H.A.N.D.S

     H.A.N.D.S  Hand Hygiene  Antisepsis  Non-touch technique  Daily inspections: ‘Is it still needed?’  Date on dressing  Documentation  Scrub the hub for 15 seconds and allow to dry

  12. Slide 12: Raise awareness of vascular access device care

     Raise awareness of vascular access device (VAD) care  A quick and simple guide to VAD care and maintenance  Reinforce the practice of Aseptic Non-Touch Technique (ANTT) when handling VADs  Decreased VAD failure due to preventable causes  Improved patient clinical outcomes

  13. Slide 13: From 'Unacceptable' to 'Best Practice'

    FROM ‘UNACCEPTABLE’ TO ‘BEST PRACTICE’

  14. Slide 14: Yes, we can!

    YES, WE CAN!

  15. Slide 15: References

     Caguioa et al. (2012) Hands: standardinsed intravascular practice based on evidence. BJN, 21 (14): S4-S11.  EPIC 3 (2014) National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection 86 (S1)  Helm et al. (2015) Acce

  16. Slide 16: References

     Steere et al. (2019) Reaching One Peripheral Intravenous Catheter (PIVC) Per Patient Visit With Lean Multimodal Strategy: the PIV5Rights Bundle. Journal of the Association for Vascular Access,24 (3):31-43.  Ullman et al. (2015) The role of the vascular access nurse practitioner in developing evid

Becton, Dickinson and Company — MDS20 (BD Medication Delivery Solutions 2020) on 6ix